MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toyota, H.
Right arrow Articles by Lovenberg, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toyota, H.
Right arrow Articles by Lovenberg, T. W.

Vol. 62, Issue 2, 389-397, August 2002

Behavioral Characterization of Mice Lacking Histamine H3 Receptors

Hiroshi Toyota, Christine Dugovic, Muriel Koehl, Aaron D. Laposky, China Weber, Karen Ngo, Ying Wu, Doo Hyun Lee, Kazuhiko Yanai, Eiko Sakurai, Takehiko Watanabe, Changlu Liu, Jingcai Chen, Ann J. Barbier, Fred W. Turek, Wai-Ping Fung-Leung, and Timothy W. Lovenberg

Johnson & Johnson Pharmaceutical Research and Development, San Diego, California (H.T., K.N., Y.W., D.H.L., C.L., J.C., A.J.B.,W.-P.F.-L., T.W.L.); Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois (C.D., M.K., A.D.L., C.W., F.W.T.); and Department of Pharmacology, Tohoku Graduate School of Medicine, Tohoku, Japan (K.Y., E.S., T.W.)

Brain histamine H3 receptors are predominantly presynaptic and serve an important autoregulatory function for the release of histamine and other neurotransmitters. They have been implicated in a variety of brain functions, including arousal, locomotor activity, thermoregulation, food intake, and memory. The recent cloning of the H3 receptor in our laboratory has made it possible to create a transgenic line of mice devoid of H3 receptors. This paper provides the first description of the H3 receptor-deficient mouse (H3-/-), including molecular and pharmacologic verification of the receptor deletion as well as phenotypic screens. The H3-/- mice showed a decrease in overall locomotion, wheel-running behavior, and body temperature during the dark phase but maintained normal circadian rhythmicity. H3-/- mice were insensitive to the wake-promoting effects of the H3 receptor antagonist thioperamide. We also observed a slightly decreased stereotypic response to the dopamine releaser, methamphetamine, and an insensitivity to the amnesic effects of the cholinergic receptor antagonist, scopolamine. These data indicate that the H3 receptor-deficient mouse represents a valuable model for studying histaminergic regulation of a variety of behaviors and neurotransmitter systems, including dopamine and acetylcholine.

Copyright © 2002 by U.S. Government


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
H. L. Haas, O. A. Sergeeva, and O. Selbach
Histamine in the Nervous System
Physiol Rev, July 1, 2008; 88(3): 1183 - 1241.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Hayashi, H. B. Cottam, M. Chan, G. Jin, R. I. Tawatao, B. Crain, L. Ronacher, K. Messer, D. A. Carson, and M. Corr
Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R123 - R132.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Le, J. A. Gruner, J. R. Mathiasen, M. J. Marino, and H. Schaffhauser
Correlation between ex Vivo Receptor Occupancy and Wake-Promoting Activity of Selective H3 Receptor Antagonists
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 902 - 909.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Teuscher, M. Subramanian, R. Noubade, J. F. Gao, H. Offner, J. F. Zachary, and E. P. Blankenhorn
Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS
PNAS, June 12, 2007; 104(24): 10146 - 10151.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
T. A. Esbenshade, G. B. Fox, and M. D. Cowart
Histamine h3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
Mol. Interv., April 1, 2006; 6(2): 77 - 88.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
E. Schneider, F. Machavoine, J.-M. Pleau, A.-F. Bertron, R. L. Thurmond, H. Ohtsu, T. Watanabe, A. H. Schinkel, and M. Dy
Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels
J. Exp. Med., August 1, 2005; 202(3): 387 - 393.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. K. Dey, H. Lim, S. K. Das, J. Reese, B. C. Paria, T. Daikoku, and H. Wang
Molecular Cues to Implantation
Endocr. Rev., June 1, 2004; 25(3): 341 - 373.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. L. Hofstra, P. J. Desai, R. L. Thurmond, and W.-P. Fung-Leung
Histamine H4 Receptor Mediates Chemotaxis and Calcium Mobilization of Mast Cells
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1212 - 1221.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
B. N Van Vliet, L. L Chafe, and J.-P. Montani
Characteristics of 24 h Telemetered Blood Pressure in eNOS-Knockout and C57Bl/6J Control Mice
J. Physiol., May 15, 2003; 549(1): 313 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Koyama, N. Seyedi, W.-P. Fung-Leung, T. W. Lovenberg, and R. Levi
Norepinephrine Release from the Ischemic Heart Is Greatly Enhanced in Mice Lacking Histamine H3 Receptors
Mol. Pharmacol., February 1, 2003; 63(2): 378 - 382.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics